CoChat

Negative regulatory approaches to the attenuation of Toll-like receptor signaling

Open access
Anwar, Muhammad Ayaz, Basith, Shaherin, Choi, Sangdun · 2013 · Experimental & Molecular Medicine
Cited by 139

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Toll-like receptors (TLRs) are pivotal components of the innate immune response, which is responsible for eradicating invading microorganisms through the induction of inflammatory molecules. These receptors are also involved in responding to harmful endogenous molecules and have crucial roles in the activation of the innate immune system and shaping the adaptive immune response. However, TLR signaling pathways must be tightly regulated because undue TLR stimulation may disrupt the fine balance between pro- and anti-inflammatory responses. Such disruptions may harm the host through the development of autoimmune and inflammatory diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Several studies have investigated the regulatory pathways of TLRs that are essential for modulating proinflammatory responses. These studies reported several pathways and molecules that act individually or in combination to regulate immune responses. In this review, we have summarized recent advancements in the elucidation of the negative regulation of TLR signaling. Moreover, this review covers the modulation of TLR signaling at multiple levels, including adaptor complex destabilization, phosphorylation and ubiquitin-mediated degradation of signal proteins, manipulation of other receptors, and transcriptional regulation. Lastly, synthetic inhibitors have also been briefly discussed to highlight negative regulatory approaches in the treatment of inflammatory diseases. The immune system is tightly regulated to strike a balance between defense against invading pathogens and inappropriate inflammatory responses. In a review article, Sangdun Choi and his colleagues at Ajou University, Korea, discuss how proteins known as ‘Toll-like receptors’ (TLRs) — the body's first line defense for detecting microbial infections — are kept in check through a number of molecular mechanisms. These include breaking up complexes of TLRs and interacting activators; downregulating the transcription and translation of TLR genes; or degrading TLR proteins directly. The molecules involved in these negative regulatory pathways provide potential therapeutic targets for treating both bacterial disease and autoimmune disorders. To that end, the authors describe a number of synthetic inhibitors that have been tested for their ability to attenuate TLR signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2013.28

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 139

Metadata

Authors
Anwar, M. A., Basith, S., & Choi, S.
Venue
Experimental & Molecular Medicine
Published
2013-02-22
Volume
45
Issue
2
Pages
e11-e11
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W1990893520
Cited by
139
References
20
FWCI
7.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.